AUTL

Autolus Therapeutics Ltd (AUTL)

US
$ 2.292.23%

Price Chart

Key Statistics

Market Cap
$ 625.42M
P/E Ratio
0.00
Revenue (TTM)
$ 9.01M
Volume
2.6M
52W High
$ 5.00
52W Low
$ 1.10
Dividend Yield
0.00%
Beta
1.81

Technicals

50-Day MA
2.2304
200-Day MA
2.3076
52 Week High
5
52 Week Low
1.105

About AUTL

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally. The company's.

Employees
647
Headquarters
London, United Kingdom
CEO
Dr. Christian Martin Itin Ph.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96